GlobeImmune's Series C Round

GlobeImmune raised a round of funding on September 14, 2007.

GlobeImmune is a biopharmaceutical company focused on developing products for the treatment of infectious disease and and oncology based on its proprietary Tarmogen platform. Tarmogens are believed to…

Articles about GlobeImmune's Series C Round: